# Terminology — Josephine Baker

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

## Diagnoses

| Use | System | Code | Display | Evidence |
|---|---|---|---|---|
| Presenting problem, resolved at the second visit | ICD-10-CM FY2026 | R06.09 | Other forms of dyspnea | S |
| Active problem | ICD-10-CM FY2026 | I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | S; linked to the documented heart attack of March 1969 |
| Active problem | ICD-10-CM FY2026 | I10 | Essential (primary) hypertension | S |
| Status, provisional | ICD-10-CM FY2026 | Z90.710 | Acquired absence of both cervix and uterus | S; linked to the retrospective account of a hysterectomy in 1941 or 1942 |
| Recorded at the second visit, resolved at the third | ICD-10-CM FY2026 | T45.525A | Adverse effect of antithrombotic drugs, initial encounter | S |
| Recorded at the second visit | ICD-10-CM FY2026 | E78.41 | Elevated Lipoprotein(a) | S |
| Social need | ICD-10-CM FY2026 | Z59.86 | Financial insecurity | S; linked to her documented debts |
| Sick visit, resolved | ICD-10-CM FY2026 | R04.0 | Epistaxis | S |

## Medications (RxNorm)

| Code | Display |
|---|---|
| 308416 | aspirin 81 MG Delayed Release Oral Tablet |
| 1116635 | ticagrelor 90 MG Oral Tablet (stopped at the second visit) |
| 309362 | clopidogrel 75 MG Oral Tablet |
| 259255 | atorvastatin 80 MG Oral Tablet |
| 866427 | 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet |
| 311354 | lisinopril 5 MG Oral Tablet (replaced at the second visit) |
| 314076 | lisinopril 10 MG Oral Tablet |
| 198039 | nitroglycerin 0.4 MG Sublingual Tablet (as needed) |

## Results (LOINC 2.81)

| Code | Measure | Unit | Category |
|---|---|---|---|
| 718-7 | Hemoglobin | g/dL | laboratory |
| 777-3 | Platelets | 10*3/uL | laboratory |
| 51990-0 | Basic metabolic panel (organizer) | — | panel |
| 2951-2, 2823-3, 2160-0, 98979-8, 2345-7 | Sodium, potassium, creatinine, eGFR (CKD-EPI 2021), glucose | mmol/L, mg/dL, mL/min/{1.73_m2} | laboratory |
| 2093-3, 13457-7, 2085-9, 2571-8 | Total cholesterol, LDL (calculated), HDL, triglycerides | mg/dL | laboratory |
| 1742-6 | ALT | U/L | laboratory |
| 4548-4 | Hemoglobin A1c | % | laboratory |
| 43583-4 | Lipoprotein(a) | nmol/L | laboratory |
| 10230-1 | Left ventricular ejection fraction | % | imaging |
| 55758-7 | PHQ-2 total score | {score} | survey |
| 44261-6 | PHQ-9 total score | {score} | survey |
| 88474-2 | Seattle Angina Questionnaire overall summary score (SAQ-7) | {score} | survey |
| 75626-2 | AUDIT-C total score | {score} | survey |

Reference ranges are typical adult female ranges chosen for the teaching record; the LDL range uses the secondary-prevention goal below 70 mg/dL, and the lipoprotein(a) range flags 125 nmol/L or higher. Home blood pressure averages, the hospital LDL of 146 mg/dL, the exercise test and the screening results (FIT, mammogram, hepatitis C, HIV, DXA, optometry) are recorded as narrative.

## Procedures, immunizations, and encounter types

- Procedures: SNOMED CT 36969009 (placement of stent in coronary artery; in the hospital before intake), 29303009 (electrocardiographic procedure), 433236007 (transthoracic echocardiography), 395697009 (cardiac rehabilitation, phase 2), 76746007 (cardiovascular stress testing) and 713603004 (advance care planning).
- Encounter types: SNOMED CT 390906007 (follow-up encounter) for the four focused chronic-care visits, 86013001 (periodic reevaluation and management of healthy individual) for the preventive visit, and 185345009 (encounter for symptom) for the sick visit. The services are named in plain text as CPT 99396 and 99497; CPT is not used as a coded value.
- Immunizations: CVX 140 (influenza, trivalent), 309 (COVID-19 mRNA), 216 (PCV20), 303 (RSV), 187 (zoster recombinant) and 115 (Tdap).
- No known allergy: SNOMED CT 716186003.

## Vital signs

The seven visits use LOINC 8302-2, 29463-7, 39156-5, 8480-6, 8462-4, 8867-4, 9279-1, 8310-5, and 59408-5 with UCUM units.

## Review note

Codes were checked against the public terminology server and NLM RxNav on November 6, 2026. They do not imply that Josephine Baker received these diagnoses, tests, or medications during her lifetime.
